Filing Details
- Accession Number:
- 0001179110-10-008579
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-13 13:00:00
- Reporting Period:
- 2010-05-11
- Filing Date:
- 2010-05-13
- Accepted Time:
- 2010-05-13 18:25:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190578 | C John Martin | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-11 | 100,000 | $3.70 | 1,734,042 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-05-11 | 80,900 | $39.52 | 1,653,142 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-11 | 19,100 | $40.00 | 1,634,042 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock option (right to buy) | Disposition | 2010-05-11 | 100,000 | $0.00 | 100,000 | $3.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 465,984 | 2011-01-17 | No | 4 | M | Direct |
Footnotes
- Sale prices reported for the transaction reported here range from $38.79 to $39.78. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transaction reported here range from $39.80 to $40.20. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
- The options had a 5-year vesting schedule. 20% of the options vested on January 18, 2002, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 18, 2006. The options expire on January 17, 2011.
Billionaire Hedge Funds
